Vetriselvan Subramaniyan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Berberine and alkaloids research 2
- Co-authors
- Vinoth Kumarasamy (9 shared papers)Riya Thapa (3 shared papers)Waleed Hassan Almalki (3 shared papers)Asif Ahmad Bhat (3 shared papers)Imran Kazmi (2 shared papers)Obaid Afzal (2 shared papers)Sami I. Alzarea (2 shared papers)Sachin Kumar Singh (4 shared papers)
- Journals
- Scientific Reports (5 papers)Toxicology Reports (4 papers)Cell Biochemistry and Biophysics (2 papers)International Journal of Nanomedicine (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- MalaysiaIndiaSaudi Arabia
In The Last Decade
Vetriselvan Subramaniyan
35 papers receiving 564 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 128
- Molecular Medicine 44
- Complementary and alternative medicine 29
- Aging 6
- Biomaterials 45
Countries citing papers authored by Vetriselvan Subramaniyan
This map shows the geographic impact of Vetriselvan Subramaniyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vetriselvan Subramaniyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vetriselvan Subramaniyan more than expected).
Fields of papers citing papers by Vetriselvan Subramaniyan
This network shows the impact of papers produced by Vetriselvan Subramaniyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vetriselvan Subramaniyan. The network helps show where Vetriselvan Subramaniyan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vetriselvan Subramaniyan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 89 | |
| 2 | 2023 | 77 | |
| 3 | 2021 | 70 | |
| 4 | 2023 | 59 | |
| 5 | 2024 | 40 | |
| 6 | 2023 | 23 | |
| 7 | 2024 | 22 | |
| 8 | 2024 | 22 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 16 | |
| 11 | 2024 | 16 | |
| 12 | 2023 | 14 | |
| 13 | 2024 | 13 | |
| 14 | 2024 | 11 | |
| 15 | 2024 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2024 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2025 | 6 |
About Vetriselvan Subramaniyan
Vetriselvan Subramaniyan is a scholar working on Molecular Biology, Pharmacology, Computational Theory and Mathematics, Pharmaceutical Science and Complementary and alternative medicine, having authored 42 papers that have together received 568 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Phytochemicals and Antioxidant Activities (4 papers), Drug Solubulity and Delivery Systems (3 papers), Cancer-related molecular mechanisms research (3 papers), Medicinal Plants and Neuroprotection (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Berberine and alkaloids research (2 papers) and Food composition and properties (2 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Medicine (44 citations), Complementary and alternative medicine (29 citations), Aging (6 citations) and Biomaterials (45 citations). Vetriselvan Subramaniyan has collaborated with scholars based in Malaysia, India and Saudi Arabia. Frequent co-authors include Vinoth Kumarasamy, Riya Thapa, Waleed Hassan Almalki, Asif Ahmad Bhat, Imran Kazmi, Obaid Afzal, Sami I. Alzarea, Sachin Kumar Singh, Mahendran Sekar and Kamal Dua. Their work appears in journals such as Scientific Reports, Toxicology Reports, Cell Biochemistry and Biophysics, International Journal of Nanomedicine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.